Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Archives of Pathology & Laboratory Medicine
|
January 28, 2020
Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing-Based Hematologic Malignancy Assays With Survey Material-Specific Differences in Variant Frequencies
Alissa Keegan, Julia A Bridge, Neal I Lindeman, et al.
The Journal of Molecular Diagnostics : JMD
|
February 17, 2015
Reporting incidental findings in genomic scale clinical sequencing--a clinical laboratory perspective: a report of the Association for Molecular Pathology
Madhuri Hegde, Sherri Bale, Pinar Bayrak-Toydemir, et al.
Archives of Pathology & Laboratory Medicine
|
April 11, 2019
Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the <i>BRAF</i>, <i>EGFR</i>, and <i>KRAS</i> Genes: A Study of the College of American Pathologists Molecular Oncology Committee
Joel T Moncur, Angela N Bartley, Julia A Bridge, et al.
JAMA Oncology
|
December 16, 2017
Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing
Annette S Kim, Angela N Bartley, Julia A Bridge, et al.
British Journal of Haematology
|
June 13, 2009
Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma
Jonathan W Friedberg, Jennifer L Kelly, Donna Neuberg, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Archives of Pathology & Laboratory Medicine
|
January 28, 2020
Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing-Based Hematologic Malignancy Assays With Survey Material-Specific Differences in Variant Frequencies
Alissa Keegan, Julia A Bridge, Neal I Lindeman, et al.
The Journal of Molecular Diagnostics : JMD
|
February 17, 2015
Reporting incidental findings in genomic scale clinical sequencing--a clinical laboratory perspective: a report of the Association for Molecular Pathology
Madhuri Hegde, Sherri Bale, Pinar Bayrak-Toydemir, et al.
Archives of Pathology & Laboratory Medicine
|
April 11, 2019
Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the <i>BRAF</i>, <i>EGFR</i>, and <i>KRAS</i> Genes: A Study of the College of American Pathologists Molecular Oncology Committee
Joel T Moncur, Angela N Bartley, Julia A Bridge, et al.
JAMA Oncology
|
December 16, 2017
Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing
Annette S Kim, Angela N Bartley, Julia A Bridge, et al.
British Journal of Haematology
|
June 13, 2009
Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma
Jonathan W Friedberg, Jennifer L Kelly, Donna Neuberg, et al.
Page
of 5